MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Quince Therapeutics, Inc. (NASDAQ: QNCX)*
Organization & Developments: Quince Therapeutics
Parents
Quince Therapeutics, Inc. (NASDAQ: QNCX)*
Children
*Developing bone-targeting drug platform capable of precisely delivering small molecules, peptides, or large molecules directly to the site of broad bone fractures and disease designed to promote more rapid healing with fewer off-target safety concerns.
*Discovery pipeline positioned for multiple skeletal therapeutic indications including osteogenesis imperfecta, fractures, spinal fusion, and other severe bone diseases
2023: Quince lays off 47% of staff, stakes sale sign for asset days after separate pipeline deal
2024: Quince Therapeutics: High-Potential Turnaround With Phase 3 Asset EryDex
2025: Quince Therapeutics: Data In Ataxia-Telangiectasia Scheduled For Early 2026
Jumps
Finance & Acquisitions: Quince Therapeutics
Key People: Quince Therapeutics